Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease

Bone Marrow Transplant. 2024 Jan;59(1):153-155. doi: 10.1038/s41409-023-02144-8. Epub 2023 Nov 6.

¹ Division of Stem Cell Transplantation and Immunotherapy, University Hospital Schleswig-Holstein and Christian-Albrechts-University Kiel, Kiel, Germany.
² Department of Pediatrics, University Hospital Schleswig-Holstein and Christian-Albrechts-University Kiel, Kiel, Germany.
³ Division of Stem Cell Transplantation and Immunotherapy, University Hospital Schleswig-Holstein and Christian-Albrechts-University Kiel, Kiel, Germany. m.gramatzki@med2.uni-kiel.de.

No abstract available

Publication types